Streetbeat News

Products Services

ACM

AECOM has been selected by the Texas Department of Transportation to provide design services for a segment of the North Houston Highway Improvement Project. The project aims to alleviate traffic congestion, enhance safety, and improve flood resiliency.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:56 am

SAGE

Sage Therapeutics has halted the development of its Alzheimer's drug, dalzanemdor, after unsatisfactory results from the Phase 2 LIGHTWAVE Study, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:54 am

MRK

Merck's Phase 3 KEYNOTE-689 trial of Keytruda for treating head and neck cancer met its primary endpoint of event-free survival and showed significant improvement in major pathological response. The safety profile was consistent with previous studies.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:48 am

KOS

Kosmos Energy received a final award in arbitration with BP Gas Marketing, prohibiting LNG sales to third parties during the contract term. The award does not impact the company's long-term financial outlook.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:38 am

SAGE

Sage Therapeutics announced that its Phase 2 LIGHTWAVE study of dalzanemdor (SAGE-718) did not meet the primary endpoint, leading to the decision to halt further development for Alzheimer's Disease. However, results from another study on Huntington's Disease are expected later this year.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:32 am

RDY

Aurigene Oncology, a subsidiary of Dr. Reddy's Laboratories, announced successful Phase 1 results for its CAR-T cell therapy, Ribrecabtagene autoleucel, in treating relapsed/refractory multiple myeloma. All 8 patients in the SWASTH study achieved clinical response, with no severe side effects reported.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:29 am

LYFT

Lyft has introduced new tools aimed at maximizing drivers' time by providing better information and recommendations. These improvements address drivers' frustrations and enhance the rewards of driving for Lyft.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:11 am

BNTX

CVAC

PFE

Pfizer and BioNTech have won a legal battle in a UK court to invalidate CureVac's patents related to mRNA technology used in COVID-19 vaccines. This decision could impact the competitive landscape in the mRNA vaccine market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 9:46 am

RIVN

Rivian Automotive (NASDAQ:RIVN) has reduced its annual EV production target due to a miscommunication with its sole supplier of copper windings, Essex Furukawa. This has led to a shortage of critical components, impacting production and causing a significant drop in Rivian's stock price.

Portfolio Pulse from Anan Ashraf

October 08, 2024 | 9:11 am

ACIC

ALCO

ALL

CB

CVNA

ENR

GNRC

HCI

HD

HIG

HRTG

KMX

L

LOW

MAS

MKL

MOS

PGR

TRV

Hurricane Milton, a Category 5 storm, is approaching Florida, impacting various stocks. Insurers like Progressive and Chubb may face losses due to expected claims. Phosphate miners like Mosaic could be affected by operational disruptions. Generac and Energizer may benefit from increased demand for generators and batteries. Home improvement retailers like Home Depot and Lowe's could see a boost from reconstruction efforts post-hurricane.

Portfolio Pulse from Shanthi Rexaline

October 08, 2024 | 8:59 am